Home › Vertex sells Incivo royalty rights for $152M
 

Keywords :   


Vertex sells Incivo royalty rights for $152M

2013-11-20 18:00:19| Biotech - Topix.net

Vertex Pharmaceuticals Inc. is selling its product royalty rights for the hepatitis C treatment Incivo for $152 million to Johnson & Johnson subsidiary Janssen Pharmaceutica.

Tags: rights sells royalty vertex

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 6A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
More »